Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

RWANDA: Health Ministry Issues Hepatitis Warning




 

allAfrica (10.13.12)

Speaking for the Rwanda Biomedical Centre (RBC), Dr. Sabin Nsanzimana, head of RBC’s HIV and other Sexually Transmitted Infectious Diseases Unit, has said that the public should take the same precautions against hepatitis that they do for HIV/AIDS. According to Nsanzimana, most prevalent in Rwanda are cases of hepatitis B at 3.6 percent—which now surpasses HIV, currently at 3 percent—and hepatitis C at 2.5 percent. Both virus strains can be transmitted through unsafe sex or primarily through contact with blood from an infected individual. It was not until two months ago when a survey was conducted, that health officials realized that Rwanda’s infection rate for hepatitis was high. Nsanzimana estimates that only 10 percent of infected persons might be getting treatment, but stresses that the ministry is doing all it can to deal with the disease. The ministry has established a unit focusing on hepatitis that is combined with the existing unit that deals with HIV/AIDS and other sexually transmitted diseases. An estimated 500 million individuals experience chronic illness related to their infection from the hepatitis virus. According to the World Health Organization (WHO), hepatitis B and C account for approximately 80 percent of all liver cancer cases.



 


Copyright © 2012 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.



Information in this article was accurate in October 15, 2012. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.